Interventional cardiologists rarely discuss metallurgy in the same breath as patient care, yet the alloy behind a coronary stent has a direct bearing on how that device performs inside a diseased artery. A cobalt chromium stent platform is now common across much of the drug-eluting stent category, having gradually taken share from earlier stainless-steel designs. The reason has less to do with marketing and more to do with basic materials science: cobalt-chromium alloys allow engineers to make thinner struts without giving up the structural strength a stent needs to hold a vessel open.
Why Does Strut Material Affect Stent Performance?
A coronary stent has to satisfy two goals that pull in opposite directions. It needs enough radial strength to resist the artery's natural tendency to recoil after balloon expansion, and it needs a low enough profile to be delivered through narrow, sometimes tortuous or calcified vessels. Thicker struts generally provide more strength but make the stent bulkier and less flexible. Thinner struts improve deliverability and are commonly discussed in the interventional literature as being associated with easier vessel wall apposition, but thinner struts made from a weaker material could compromise scaffolding. Alloy selection is the engineering lever that lets manufacturers address both goals at once.
What Makes Cobalt-Chromium Different From Stainless Steel?
Cobalt-chromium alloys, including the L605 grade commonly used in coronary devices, generally have a higher density and higher tensile strength than the 316L stainless steel used in earlier-generation stents. This higher strength-to-thickness ratio means a cobalt-chromium strut can be made noticeably thinner than a stainless-steel strut while still providing comparable radial strength. That combination is a primary reason cobalt-chromium became a preferred platform material as drug-eluting stent designs matured, since it allowed manufacturers to reduce strut profile without simply trading away scaffolding force.
Radial Strength and Its Role in Vessel Support
Radial strength refers to a stent's resistance to being compressed back down after it has been expanded against the vessel wall. This property matters most in the days and weeks following implantation, before the stent becomes incorporated into the arterial wall through the body's healing response. A stent with adequate radial strength is expected to keep the treated segment open even as forces from the surrounding tissue and blood flow act on it. Alloy composition, strut thickness, and stent design geometry all contribute together to the final radial strength profile of a given device.
The ATLAS System's Cobalt-Chromium L605 Platform
The ATLAS Drug Eluting Coronary Stent System, manufactured by INVAMED, is built on a cobalt-chromium L605 alloy platform with a strut thickness reported by the manufacturer at 60 µm. The manufacturer describes this combination as supporting durable radial strength and trackability, including in complex or calcified coronary lesions, while also carrying a sirolimus drug coating intended to help limit restenosis. Full technical specifications and the Instructions for Use (IFU) are available on the ATLAS Drug Eluting Coronary Stent System product page. As with any coronary device, availability and specific indications vary by country.
Does Stainless Steel Still Have a Role in Modern Stents?
Stainless steel remains a well-established and viable platform material for certain coronary and peripheral stent applications. Some clinical scenarios and device categories continue to use stainless-steel scaffolds effectively, and the choice between stainless steel and cobalt-chromium platforms is generally guided by the specific device design, intended lesion type, and the treating physician's clinical judgment rather than one material being universally superior to the other. Both categories of alloy have an established track record in coronary intervention, and a qualified physician determines which device platform is appropriate for a given patient's anatomy.
What does the "L605" designation actually refer to?
L605 is a specific grade of cobalt-chromium alloy commonly used in medical device manufacturing, defined by its particular mix of cobalt, chromium, nickel, and tungsten. This grade is selected for coronary stent platforms generally because of its combination of strength, corrosion resistance, and biocompatibility.
Is a thinner stent strut always the better choice?
Not necessarily. Strut thickness is one variable among several, including alloy strength, stent design, and drug coating, that together determine how a device performs in a given lesion. A qualified physician weighs these factors alongside the patient's specific vessel anatomy when selecting a stent.
Can alloy choice affect how visible a stent is on imaging?
Alloy composition can influence radiopacity, meaning how clearly a stent shows up under fluoroscopic imaging during and after the procedure. This is one of several engineering considerations, alongside strength and strut profile, that factor into overall stent platform design.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.